New Form 8-K - Envoy Medical, Inc. Filed: 2025-08-26 AccNo: 0001213900-25-080530 Size: 296 KB Item 1.02: Termination of a Material Definitive Agreement Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Westlake anuncia la adquisición de ACI Compounding Solutions Business
Health Catalyst Announces Upfront: Market Insights on Salesforce AppExchange
Veracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer Test
Initial Data Shows 100% Disease Control in 5 Out of 5 Patients With Recurrent Glioblastoma With Two Patients in Near Complete Response Treated With ImmunityBio’s ANKTIVA®, NK Cell Therapy Plus Optune Gio® Device
DexCom, Inc. - Dexcom Announces Upcoming Conference Presentations
National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced
Dexcom Announces Upcoming Conference Presentations
CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy
Odyssey Health, Inc. to Advance Development of its Save A Life Choking Rescue Device
Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress